These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2578185)

  • 21. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
    Dawbarn D; Zamir N; Waters CM; Hunt SP; Emson PC; Brownstein MJ
    Brain Res; 1986 Apr; 372(1):155-8. PubMed ID: 2871898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders.
    Goto S; Hirano A; Rojas-Corona RR
    Acta Neuropathol; 1989; 78(5):543-50. PubMed ID: 2479214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatostatin is increased in the basal ganglia in Huntington disease.
    Aronin N; Cooper PE; Lorenz LJ; Bird ED; Sagar SM; Leeman SE; Martin JB
    Ann Neurol; 1983 May; 13(5):519-26. PubMed ID: 6191621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcineurin in human brain and its relation to extrapyramidal system. Immunohistochemical study on postmortem human brains.
    Goto S; Matsukado Y; Mihara Y; Inoue N; Miyamoto E
    Acta Neuropathol; 1986; 72(2):150-6. PubMed ID: 2950715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study.
    Waeber C; Palacios JM
    Neuroscience; 1989; 32(2):337-47. PubMed ID: 2531301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.
    Mauborgne A; Javoy-Agid F; Legrand JC; Agid Y; Cesselin F
    Brain Res; 1983 May; 268(1):167-70. PubMed ID: 6190539
    [No Abstract]   [Full Text] [Related]  

  • 27. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease.
    Utal AK; Stopka AL; Roy M; Coleman PD
    Neuroscience; 1998 Oct; 86(4):1055-63. PubMed ID: 9697113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases.
    Goodchild RE; Court JA; Hobson I; Piggott MA; Perry RH; Ince P; Jaros E; Perry EK
    Eur J Neurosci; 1999 Feb; 11(2):449-56. PubMed ID: 10051746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy.
    Kanazawa I; Sasaki H; Muramoto O; Matsushita M; Mizutani T; Iwabuchi K; Ikeda T; Takahata N
    J Neurol Sci; 1985 Sep; 70(2):151-65. PubMed ID: 2865338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
    Buck SH; Burks TF; Brown MR; Yamamura HI
    Brain Res; 1981 Mar; 209(2):464-9. PubMed ID: 6164436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions.
    Marksteiner J; Saria A; Kirchmair R; Pycha R; Benesch H; Fischer-Colbrie R; Haring C; Maier H; Ransmayr G
    Eur J Neurosci; 1993 Dec; 5(12):1573-85. PubMed ID: 7510203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A detailed examination of substance P in pathologically graded cases of Huntington's disease.
    Beal MF; Ellison DW; Mazurek MF; Swartz KJ; Malloy JR; Bird ED; Martin JB
    J Neurol Sci; 1988 Mar; 84(1):51-61. PubMed ID: 2452859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
    Nisbet AP; Eve DJ; Kingsbury AE; Daniel SE; Marsden CD; Lees AJ; Foster OJ
    Neuroscience; 1996 Nov; 75(2):389-406. PubMed ID: 8931005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.
    Taquet H; Javoy-Agid F; Cesselin F; Hamon M; Legrand JC; Agid Y
    Brain Res; 1982 Mar; 235(2):303-14. PubMed ID: 7188329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
    Betarbet R; Greenamyre JT
    Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.
    Bartzokis G; Tishler TA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):821-33. PubMed ID: 10875443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405
    [No Abstract]   [Full Text] [Related]  

  • 40. The comparison between enkephalin-like and dynorphin-like immunoreactivity in both monkey and human globus pallidus and substantia nigra.
    Haber SN; Watson SJ
    Life Sci; 1983; 33 Suppl 1():33-6. PubMed ID: 6141493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.